According to the companies, an objective response rate of 54.8% was observed with Daiichi Sankyo and Merck's ifinatamab deruxtecan at a 12 mg/kg dose in pretreated patients. This dose has been ...

In addition, of course, as for other interstitial lung disease, we do want a lung function test to know the baseline values for FVC [forced vital lung capacity], FEV 1 [forced expiratory volume ...

The antibody–drug conjugate ifinatamab deruxtecan (I-DXd ... according to an interim analysis of the Phase ... Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease ...

BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--Results from an interim analysis of the dose-optimization part of the ongoing IDeate-Lung01 phase 2 trial showed ifinatamab deruxtecan (I-DXd ...

Reliable prognostic tools to help shed light on the critical clinical characteristics associated with progressive pulmonary fibrosis in interstitial lung disease patients would help guide treatment A ...

Also, at WCLC, an oral presentation will highlight efficacy and safety data from Part 1 of the DESTINY-Lung03 Phase Ib trial of ENHERTU ® (fam-trastuzumab deruxtecan-nxki) in patients with ...

Source: Getty Images Metastatic breast cancer is breast cancer that has spread beyond the breast and lymph nodes into other organs, most commonly the bones, brain, liver, and/or lungs. Metastasis ...

Daiichi Sankyo granted Merck exclusive, worldwide rights (excluding Japan) to co-develop and co-commercialize Daiichi's 3 antibody-drug conjugates (ADCs) including patritumab deruxtecan (HER3-DXd ...

Interstitial Lung Fibrosis or interstitial lung disease (ILD) is a group of diseases that cause scarring of the lungs (fibrosis) or lung parenchyma. If untreated it can lead to respiratory failure and ...

When David Lo first visited the Salton Sea shore in the spring of 2018, he was struck by the sheer oddness of the place: the beach of barnacle shells and pulverized fish bones; the abandoned dock ...